by Madaline Spencer | Jul 15, 2025
Takeda has announced positive data from two phase 3 clinical trials of oveporexton in patients with narcolepsy type 1 (NT1). NT1 is a rare, chronic neurological disorder characterized by excessive daytime sleepiness (EDS) and cataplexy. It is caused by reduced levels...
by Madaline Spencer | Jul 15, 2025
David Liang, MD, PhD, Cardiologist at Hoag Hospital, discusses the diagnosis and management of Marfan syndrome. Marfan syndrome is a rare genetic disorder characterized by problems in the development of connective tissue. This leads to changes in the...
by Madaline Spencer | Jul 14, 2025
David Kuter, MD, DPhil, Director of Clinical Hematology at Massachusetts General Hospital, discusses recent results of a trial of mezagitamab in patients with immune thrombocytopenia (ITP). ITP is an autoimmune bleeding disorder characterized by too few...
by Madaline Spencer | Jul 11, 2025
Surbhi Sidana, MD, Hematologist and Associate Professor at Stanford University, discusses effects of ciltacabtagene autoleucel (cilta-cel) in patients with multiple myeloma (MM). MM is a bone marrow-based plasma cell neoplasm characterized by a serum...
by Madaline Spencer | Jul 10, 2025
Michael J. Thorpy, MD, Professor of Neurology at Albert Einstein College of Medicine, discusses positive results in study of Lumryz (sodium oxybate) for hallucinations in patients with narcolepsy. Narcolepsy is a chronic neurological disorder...
